Oral Session

[O4] Oral Session 4"Immune/Cardiovascular/Regenerative medicine/Others "

Mon. Sep 11, 2023 4:40 PM - 5:50 PM Room 3 (1008, 10Ｆ, OICC)

Chairs:Junichi Mineno（Takara Bio Inc.）,Ryosuke Uchibori（Division of gene and cell therapy for intractable diseases, Department of Medicine, Jichi Medical University）

+Add all to schedule

[O4-1] Reovirus induces tumor infiltration of CD8+ T cells in an IPS-1-independent manner

^○Fuminori Sakurai¹, Maho Eguchi¹, Naomi Shuwari¹, Masashi Tachibana^1,2, Ken J Ishii^3,4, Hiroyuki Mizuguchi^1,2,4,5,6 (1.Grad. Sch. Pharm. Sci., Osaka Univ., 2.Ctr. Adv. Med. Engin. Inform., Osaka Univ, 3.Insti. Med. Sci., Univ. Tokyo, 4.Nat. Inst. Biomed. Innov. Health Nutr., 5.OTRI, Osaka Univ., 6.CiDER, Osaka Univ.)

[O4-2] Development of a neutralizing antibody assay for different AAV serotypes using HEK293 cells

^○Ryota Watano¹, Kenji Ohba¹, Yoshihide Sehara¹, Yasushi Saga², Masashi Urabe¹, Hiroaki Mizukami¹ (1.Division of Genetics Therapeutics, Center for Molecular Medicine, Jichi Medical University, 2.Department of Obstetrics and Gynecology, Jichi Medical University)

[O4-3] Gene Therapy for Hypertrophic Cardiomyopathy Model Mice

^○Hideki Uosaki¹, Tatsuya Azumi^1,2, Ryo Kawakami³, Takeshi Tokuyama¹, Razan Ahmed¹, Fuad Gandhi Torizal¹, Yasumitsu Nagao⁴, Hideki Ishii³, Norimichi Koitabashi³ (1.Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University, 2.Department Pediatrics, Jichi Medical University, 3.Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 4.Center for Experimental Medicine, Jichi Medical University)

[O4-4] Alveolar bone regeneration following bmp-2 gene transfer into the periodontal tissue

^○Mariko Yamamoto Kawai^1,2 (1.Kansai Women's Collage, 2.Kyoto University)

[O4-5] Liver-specific overexpression of lysophospholipid acyltransferase 10 (LPLAT10) increases glucose-dependent insulin secretion

^○Kahori Shimizu¹, Moe Ono¹, Takenari Mikamoto¹, Yuya Urayama¹, Hiroki Nakanishi², Shotaro Michinaga³, Sena Yoshida¹, Miho Iwasaki¹, Tomoyuki Terada¹, Fuminori Sakurai⁴, Hiroyuki Mizuguchi^4,5,6,7,8, Hideo Shindou^9,10, Koji Tomita¹, Toru Nishinaka¹ (1.Pharm., Osaka Ohtani Univ., 2.Lipidome Lab Co., Ltd., 3.Meiji Pharm. Univ., 4.Grad. Sch. of Pharma. Sci., Osaka Univ., 5.Natl. Inst. of Biomed. Innov. Health Nutr., 6.MEIC, Osaka Univ., 7.OTRI, Osaka Univ., 8.CiDER, Osaka Univ., 9.NCGM, 10.Univ. of Tokyo)

[O4-6] Identification of an intron sequence to enhance the liver transduction by AAV vector

^○Tsukasa Ohmori, Nobuhiko Kamoshita, Morisada Hayakawa, Yuji Kashiwakura, Nemekhbayar Baatartsogt (Jichi Medical University School of Medicine)

[O4-7] New modality of vaccine by AAV vector and extracellular vesicle

^○Yasunari Matsuzaka, Ken Sugo, Hiroto Kodera, Yuji Tsunekawa, Hiromi Kinoh, Miho Nagoya, Mikako Wada, Yuko Kasahara, Ykihiko Hirai, Takashi Okada (Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)